Return to content in this issue

 

Adyuvant use of omalizumab in desensitization to chemotherapeutics: beyond ige-mediated reactions

Prieto-García A, Rojas P, Noguerado B, Zambrano G, Cuevas C, Juárez A, Tornero P


Allergy Service. University Hospital Gregorio Marañón, Institute for Health Research Gregorio Marañón, Madrid, Spain.

J Investig Allergol Clin Immunol 2023; Vol. 33(6)
doi: 10.18176/jiaci.0911

Key words: Drug allergy, Drug desensitization, Chemotherapeutics, Omalizumab, Premedication